Patheon’s flexible manufacturing facilities enable biotechnology companies to reduce their capital investments and manage variable product demand whether they are a start-up or global company. Utilizing Patheon as a strategic partner in the development of your product allows you to minimize your infrastructure costs and dedicate your resources to product discovery.
Patheon provides you with access to our high-quality cGMP compliant facilities, supplemented with scientific expertise in dosage form development, process development and scale-up, and global regulatory requirements for Clinical Trial Materials (CTM). Our Project Managers use a matrix approach to efficiently manage a wide range of biotech customers throughout our global infrastructure.
In addition to stand-alone services, Patheon provides expert solutions for biotech companies interested in the management of their product throughout its lifecycle. Patheon scientists apply customized development programs that are scalable, seamlessly and efficiently progressing your product from the development cycle through to commercial launch. Our expertise with a broad range of actives includes biopharmaceutical products such as peptides, proteins, and monoclonal antibodies (MAbs).
Our Quick to Clinic™ programs are dedicated to saving valuable time in preparing your molecule for First Time in Human (FTIH) clinical trials. These programs can be especially valuable for start-up companies who need to prioritize their resources by rapidly examining the potential of their early phase products.